2393 Stock Overview
An investment holding company, manufactures and sells medical imaging products in Mainland China. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Yestar Healthcare Holdings Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.063 |
| 52 Week High | HK$0.23 |
| 52 Week Low | HK$0.016 |
| Beta | 0.090 |
| 1 Month Change | -8.70% |
| 3 Month Change | 34.04% |
| 1 Year Change | -19.23% |
| 3 Year Change | -94.66% |
| 5 Year Change | -95.77% |
| Change since IPO | -84.05% |
Recent News & Updates
These 4 Measures Indicate That Yestar Healthcare Holdings (HKG:2393) Is Using Debt Extensively
Nov 21
Yestar Healthcare Holdings' (HKG:2393) Attractive Earnings Are Not All Good News For Shareholders
Sep 19Recent updates
These 4 Measures Indicate That Yestar Healthcare Holdings (HKG:2393) Is Using Debt Extensively
Nov 21Yestar Healthcare Holdings' (HKG:2393) Attractive Earnings Are Not All Good News For Shareholders
Sep 19Yestar Healthcare Holdings (HKG:2393) Seems To Be Using A Lot Of Debt
Dec 13These Return Metrics Don't Make Yestar Healthcare Holdings (HKG:2393) Look Too Strong
Oct 18Is Yestar Healthcare Holdings (HKG:2393) Using Too Much Debt?
Sep 05One Yestar Healthcare Holdings Company Limited (HKG:2393) Analyst Has Been Cutting Their Forecasts
Sep 05Returns On Capital At Yestar Healthcare Holdings (HKG:2393) Have Hit The Brakes
Jun 10These 4 Measures Indicate That Yestar Healthcare Holdings (HKG:2393) Is Using Debt Extensively
Apr 18What Kind Of Investors Own Most Of Yestar Healthcare Holdings Company Limited (HKG:2393)?
Mar 15The Returns At Yestar Healthcare Holdings (HKG:2393) Provide Us With Signs Of What's To Come
Feb 07A Look At Yestar Healthcare Holdings' (HKG:2393) Share Price Returns
Dec 21Do Institutions Own Yestar Healthcare Holdings Company Limited (HKG:2393) Shares?
Nov 30
Shareholder Returns
| 2393 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | -1.6% | 1.3% | 1.5% |
| 1Y | -19.2% | -26.7% | 20.6% |
Return vs Industry: 2393 exceeded the Hong Kong Medical Equipment industry which returned -26% over the past year.
Return vs Market: 2393 underperformed the Hong Kong Market which returned 22.4% over the past year.
Price Volatility
| 2393 volatility | |
|---|---|
| 2393 Average Weekly Movement | 32.2% |
| Medical Equipment Industry Average Movement | 9.0% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in HK Market | 18.6% |
| 10% least volatile stocks in HK Market | 4.0% |
Stable Share Price: 2393's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2393's weekly volatility (32%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1971 | 726 | Changxiang Liao | www.yestarcorp.com |
Yestar Healthcare Holdings Company Limited, an investment holding company, manufactures and sells medical imaging products in Mainland China. It operates through two segments: Imaging Printing Products, and Medical Products and Equipment. The Imaging Printing Products segment manufactures and sells Fujifilm color photographic paper, industrial NDT X-ray films, and PWB films; and trades in imaging equipment.
Yestar Healthcare Holdings Company Limited Fundamentals Summary
| 2393 fundamental statistics | |
|---|---|
| Market cap | HK$146.89m |
| Earnings (TTM) | HK$1.15b |
| Revenue (TTM) | HK$2.89b |
0.1x
P/E Ratio0.1x
P/S RatioIs 2393 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2393 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.71b |
| Cost of Revenue | CN¥2.29b |
| Gross Profit | CN¥426.15m |
| Other Expenses | -CN¥651.84m |
| Earnings | CN¥1.08b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.46 |
| Gross Margin | 15.70% |
| Net Profit Margin | 39.72% |
| Debt/Equity Ratio | 44.8% |
How did 2393 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 08:42 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Yestar Healthcare Holdings Company Limited is covered by 10 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Paul Rodger Snelgrove | CGS International |
| Timothy Lee | CLSA |
| Jie Sheng Liu | Credit Suisse |